Document Detail

Management of asthma by pregnant women attending an Australian maternity hospital.
MedLine Citation:
PMID:  22141407     Owner:  NLM     Status:  Publisher    
Aims:  The safety of preventive asthma medicines during pregnancy has already been established. The aim of this study was to assess asthma management by women during pregnancy. Methods:  Pregnant women attending the out-patient clinics of an Australian maternity hospital completed a questionnaire about their asthma medication use and symptoms. Parameters associated with changes in asthma medicine use are presented as odds ratio with a 95% confidence level. P-values <0.05 indicated statistical significance. Results:  Participants (n = 102) self-reported worsening of their asthma symptoms during pregnancy compared with the pre-pregnancy period, both during the day (P = .003) and night (P = .044). The number of participants whose asthma was treated by a medical professional decreased from 81 (79.4%) before pregnancy to 67 (65.7%) during pregnancy (P = .008). The use of regular asthma medicines (preventers and symptom controllers alone or in combination) decreased during pregnancy (P < .001 and P = .012, respectively), while the use of intermittent therapies (relievers) increased (P = .004) during pregnancy. Being treated by a medical professional during pregnancy (P = .033), a history of asthma medicine use before pregnancy (P = .015) and younger age of first asthma diagnosis (P = .046) were associated with the use of asthma medicines during pregnancy. Conclusions:  Despite worsening of asthma symptoms, many pregnant women do not take regular preventive asthma medicines. Ongoing assessment of asthma control during pregnancy, medication review and adjustments in therapy by health professionals might facilitate asthma management.
Emilia Sawicki; Kay Stewart; Swee Wong; Eldho Paul; Laura Leung; Johnson George
Related Documents :
22014247 - Efficacy of a physicians' pocket guide about prenatal substance use: a randomized trial.
21815917 - Equine amnionitis and fetal loss: mare abortion following experimental exposure to proc...
22103297 - High prevalence of unintended pregnancies in hiv-positive women of reproductive age in ...
21875397 - Uptake of cobalamin and markers of cobalamin status: a longitudinal study of healthy pr...
21193037 - Assisted reproduction technologies alter steroid delivery to the mouse fetus during pre...
7529457 - Disturbed zinc metabolism and reduced birthweight related to raised maternal serum alph...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-12-6
Journal Detail:
Title:  The Australian & New Zealand journal of obstetrics & gynaecology     Volume:  -     ISSN:  1479-828X     ISO Abbreviation:  -     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-6     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0001027     Medline TA:  Aust N Z J Obstet Gynaecol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2011 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology © 2011 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University, Royal Parade, Parkville, Victoria, Australia Division of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, the Netherlands Department of Pharmacy, The Royal Women's Hospital, Parkville Department of Epidemiology and Preventive Medicine, Monash University, Alfred Hospital, Victoria, Australia.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  In vitro antiplasmodial activity and cytotoxicity of extracts and fractions of Vitex madiensis, medi...
Next Document:  Effects of Acute Inflammation Induced in the Rat Paw on the Deep Digital Flexor Tendon.